Healthtech Startups

Renova Therapeutics develops investigational gene therapies intended as single-dose, long-lasting treatments for common chronic diseases, with an initial focus on congestive heart failure and type 2 diabetes. The company builds a platform of therapeutics and delivery systems based on proprietary insights into disease mechanisms.

1 investor

Renovion develops ARINA-1, a next-generation mucolytic therapy delivered as a sterile buffered ascorbic acid and glutathione solution to the lungs. The therapy targets chronic inflammatory airway diseases affecting over 170 million patients globally, including non-cystic fibrosis bronchiectasis, chronic bronchitis, COPD, and asthma.

1 investor

1 investor

Renovo Solutions operates a Life Sciences business line providing services and solutions to pharmaceutical, biotech, medical device, and laboratory services companies.

1 investor

RenovoDerm is a life sciences company developing wound care and tissue technology platforms within the medtech and biotech sectors. It operates as a commercial subsidiary of Paragen Technologies.

1 investor

Reopia develops advanced optical solutions that prevent the onset and progression of myopia in children. The company addresses the growing global epidemic of nearsightedness through medical devices targeting pediatric eye health.

1 investor

RepOne provides strength training software and hardware integration tools that enable coaches and athletes to automate workout programming and real-time performance tracking at an affordable cost. The platform targets amateur athletes, professional coaches, and fitness enthusiasts across all experience levels.

1 investor

REPROCELL provides research services and products for stem cell and drug discovery scientists, including iPSC tools, gene editing, GMP cell manufacturing, human tissue testing, and biospecimen processing. It serves cell therapy developers, stem cell researchers, diagnostic developers, and preclinical and clinical drug developers across the research-to-clinic pipeline.

1 investor

REPROSENT captures patient treatment experience data to support dose, safety, and development decisions in oncology and advanced cancer therapies. The platform operates as a lightweight, non-interventional overlay on existing clinical trials and care programs, converting patient symptoms into structured, computable signal for development and clinical teams.

1 investor

Reschedule provides software for medical residency programs to create and manage their schedules, offering an end-to-end workflow for graduate medical education scheduling in hospitals. It addresses scheduling logistics for residency programs.

1 investor

Rescripted is a digital health platform for women's health covering fertility, pregnancy, menstrual health, sexual health, and chronic condition management, featuring AI-powered health guidance reviewed by medical experts.

1 investor

Rescription operates a pharmacy benefit management company that uses patented technology to deliver transparent, real-time prescription pricing with aligned financial incentives. The company serves self-funded employers, health systems, PBMs, and their members across the United States by applying cost savings at the point of prescription filling rather than through delayed rebate reconciliation.

1 investor

Rescue Swag manufactures durable, comprehensive first aid kits designed for Australian environments, sold with 100% of profits supporting the Royal Flying Doctor Service, a national charitable aeromedical organization.

1 investor

Everlife-Research Instruments supplies research tools, laboratory equipment, and analytical solutions to the scientific and clinical community in Asia. The company provides a full range of services from product distribution to technical support, regulatory guidance, and laboratory design.

1 investor

ResetSmile provides at-home tooth replacement solutions using a patented system that allows patients to replace missing teeth without visiting a dental office. The company serves the approximately 140 million Americans who have been underserved by traditional dental care options.

1 investor

Residence Home Care provides skilled in-home health care services, including physician-coordinated assessments and treatments delivered by clinical professionals at patients' homes. It is a Medicare-certified, ACHC-accredited agency with services covered through Medicare, Medicaid, or private insurance.

1 investor

Resilient Medical Corp designs an implantable device, Bravo, placed during breast cancer lumpectomy surgery to support tissue healing, avoid follow-up cosmetic reconstruction, and act as a radiocontrast marker for post-operative therapy. The company targets breast cancer surgical patients and clinicians in the medical device industry.

1 investor

Resistomap provides environmental surveillance and monitoring solutions for antibiotic resistance using microbiology and data science expertise. The company serves global communities, organizations, and projects focused on tracking antibiotic resistance across environmental, animal, and human health domains.

1 investor

Resmonics develops software tools for preventing, monitoring, and assessing acute and chronic respiratory diseases, providing objective clinical insights to patients and healthcare professionals. The company focuses on digital health solutions in the software-as-medical-device category.

1 investor

Resolian is a Contract Research Organization (CRO) that provides bioanalytical, biomarker, and analytical sciences services to support drug development for pharma and biotech companies. The company specializes in GxP and non-regulated bioanalysis, drug metabolism and pharmacokinetic services, and GMP CMC analytical and materials science across all therapeutic modalities.

1 investor

Resolution develops a macrophage cell therapy to treat end-stage liver disease, aiming to reduce the need for liver transplantation and improve patient outcomes. The company focuses on regenerative medicine for inflammatory and fibrotic diseases.

1 investor

Resolve Nanotherapeutics is developing RNA drugs delivered via lipid nanoparticles that amplify the body's toxin-clearance pathway to treat severe acute bacterial infections and their chronic complications. Its host-focused therapy targets the immune system rather than the bacteria, aiming to work against antibiotic-resistant infections in critical care settings.

1 investor

Resolve Sleep Health operates Canada's largest network of sleep clinics, providing in-person and virtual diagnostic and therapeutic services for sleep disorders, particularly obstructive sleep apnea. The company serves Canadian patients across multiple provinces with personalized care and multilingual support.

1 investor

1 investor